Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Financial Statements

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Financial Overview

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H's market cap is currently HK$19.77B. The company's EPS TTM is HK$0.43; its P/E ratio is 25.33; Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H is scheduled to report earnings on April 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 1.38B	¥ 980.45M	¥ 716.91M	¥ 533.88M	¥ 354.56M
Gross Profit	¥ 1.05B	¥ 761.52M	¥ 506.03M	¥ 391.75M	¥ 247.44M
Operating Income	¥ 278.60M	¥ 164.37M	¥ -270.29M	¥ -530.44M	¥ -505.82M
EBITDA	¥ 419.49M	¥ 303.80M	¥ -97.87M	¥ -465.86M	¥ -378.12M
Net Income	¥ 173.20M	¥ 33.54M	¥ -382.95M	¥ -602.16M	¥ -545.58M
Balance Sheet
Cash & Short-Term Investments	¥ 1.56B	¥ 381.18M	¥ 408.09M	¥ 611.27M	¥ 566.45M
Total Assets	¥ 3.72B	¥ 2.42B	¥ 2.45B	¥ 2.80B	¥ 2.30B
Total Debt	¥ 584.09M	¥ 570.28M	¥ 544.11M	¥ 415.28M	¥ 89.80M
Net Debt	¥ -978.92M	¥ 189.09M	¥ 144.51M	¥ -187.79M	¥ 71.91M
Total Liabilities	¥ 1.54B	¥ 1.58B	¥ 1.66B	¥ 1.65B	¥ 1.05B
Stockholders' Equity	¥ 2.17B	¥ 834.06M	¥ 785.89M	¥ 1.15B	¥ 1.25B
Cash Flow
Free Cash Flow	¥ 282.43M	¥ 174.12M	¥ -203.26M	¥ -543.94M	¥ -564.45M
Operating Cash Flow	¥ 370.25M	¥ 211.25M	¥ -76.65M	¥ -303.27M	¥ -365.78M
Investing Cash Flow	¥ -184.86M	¥ -137.12M	¥ -100.28M	¥ -153.74M	¥ -84.13M
Financing Cash Flow	¥ 979.86M	¥ -92.03M	¥ -37.82M	¥ 587.20M	¥ 219.44M

Currency in CNY

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Earnings and Revenue History

Income Statement >

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Debt to Assets

Balance Sheet >

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Cash Flow

Cash Flow >

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Forecast EPS vs Actual EPS

Earnings >